1. Home
  2. MLYS vs JBLU Comparison

MLYS vs JBLU Comparison

Compare MLYS & JBLU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mineralys Therapeutics Inc.

MLYS

Mineralys Therapeutics Inc.

HOLD

Current Price

$20.29

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Logo JetBlue Airways Corporation

JBLU

JetBlue Airways Corporation

HOLD

Current Price

$2.93

Market Cap

2.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLYS
JBLU
Founded
2019
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Air Freight/Delivery Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.1B
IPO Year
2023
2002

Fundamental Metrics

Financial Performance
Metric
MLYS
JBLU
Price
$20.29
$2.93
Analyst Decision
Strong Buy
Sell
Analyst Count
11
17
Target Price
★ $46.33
$4.58
AVG Volume (30 Days)
1.4M
★ 19.0M
Earning Date
11-09-2026
10-27-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 37.43
27.83
EPS
N/A
★ N/A
Revenue
N/A
★ $9,062,000,000.00
Revenue This Year
N/A
$15.42
Revenue Next Year
N/A
$8.26
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$20.41
$2.98
52 Week High
$47.65
$6.62

Technical Indicators

Market Signals
Indicator
MLYS
JBLU
Relative Strength Index (RSI) 32.24 19.33
Support Level N/A N/A
Resistance Level $31.19 $6.22
Average True Range (ATR) 1.27 0.16
MACD -0.29 -0.10
Stochastic Oscillator 4.06 1.06

Price Performance

Historical Comparison
MLYS
JBLU

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a biopharmaceutical company focused on developing medicines to target diseases driven by dysregulated aldosterone. The Company's product candidate, lorundrostat, is a proprietary, orally administered, aldosterone synthase inhibitor that the Company is developing for the treatment of cardiorenal conditions affected by dysregulated aldosterone, including hypertension and related comorbidities, such as chronic kidney disease and obstructive sleep apnea. Its product candidate, lorundrostat, is a proprietary, orally administered, selective ASI that is designed to reduce aldosterone levels by inhibiting CYP11B2, the enzyme responsible for producing the hormone.

About JBLU JetBlue Airways Corporation

JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It served approximately 100 destinations in the United States, the Caribbean and Latin America, Canada, and England. The company currently operates Airbus A321, Airbus A320, Airbus A321neo, and Embraer E190 aircraft types. The company has one operating segment, Air Transportation Services, which provides services in the United States, the Caribbean, Latin America, Canada, and Europe. The majority of revenue is generated from the Domestic & Canada segment.

Share on Social Networks: